TY - JOUR
T1 - Metabolic abnormalities in HIV disease and injection drug use
AU - Dobs, Adrian
AU - Brown, Todd
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2002/10/1
Y1 - 2002/10/1
N2 - HIV infection is associated with a number of adverse consequences, including metabolic disorders. This article reviews disorders such as wasting, lipid metabolism disorders (including fat redistribution or dyslipidemia), glucose abnormalities, bone disease, and endocrine disorders such as hypogonadism in the presence of HIV infection and/or drug abuse. The issues covered are current estimations of prevalence, risk factors, underlying pathophysiology, diagnosis, and interventions (prevention and treatment) for metabolic complications of HIV and drug abuse.
AB - HIV infection is associated with a number of adverse consequences, including metabolic disorders. This article reviews disorders such as wasting, lipid metabolism disorders (including fat redistribution or dyslipidemia), glucose abnormalities, bone disease, and endocrine disorders such as hypogonadism in the presence of HIV infection and/or drug abuse. The issues covered are current estimations of prevalence, risk factors, underlying pathophysiology, diagnosis, and interventions (prevention and treatment) for metabolic complications of HIV and drug abuse.
KW - HIV/AIDS
KW - Metabolic disorders
UR - http://www.scopus.com/inward/record.url?scp=0036800160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036800160&partnerID=8YFLogxK
U2 - 10.1097/00126334-200210012-00007
DO - 10.1097/00126334-200210012-00007
M3 - Article
C2 - 12394785
AN - SCOPUS:0036800160
SN - 1525-4135
VL - 31
SP - S70-S77
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - SUPPL. 2
ER -